Symbiosis Pharmaceutical Services Ltd (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has announced the completion of a £1.3 million collaborative UKRI-funded project as part of the medicines manufacturing challenge. Symbiosis and The Cell and Gene Therapy Catapult (CGT Catapult) have successfully developed and demonstrated a lean manufacturing supply chain in partnership with Freeline Therapeutics for the sterile filling and manufacturing process of drug product.The project learnings will now accelerate the manufacturing supply chain for ATMPs within the UK. John McCormick, COO of Symbiosis said: “The results
The post Symbiosis announces successful completion of UK Research and Innovation (UKRI) project, which will enhance the manufacturing supply chain for ATMPs within the UK appeared first on Pharma Mirror Magazine.
